The zebrafish as a novel system for functional genomics and therapeutic development applications

A. Nasevicius, Stephen C Ekker

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Unconventional antisense technology has entered the mainstream for both therapeutic and functional genomics applications in a variety of biological settings. Further development of this approach has been hampered by the high cost and limited information obtained with standard bioassays and animal models. The embryo of the zebrafish Danio rerio offers both biologists and technologists a new strategy that rapidly garners efficacy, toxicity and specificity data in an in vivo setting. This system has been used to optimize current antisense targeting methods, and it provides an ideal initial assay system for the development of new chemistries or other new gene targeting approaches.

Original languageEnglish (US)
Pages (from-to)224-228
Number of pages5
JournalCurrent Opinion in Molecular Therapeutics
Volume3
Issue number3
StatePublished - 2001
Externally publishedYes

Fingerprint

Zebrafish
Genomics
Gene Targeting
Biological Assay
Embryonic Structures
Animal Models
Technology
Costs and Cost Analysis
Therapeutics

Keywords

  • Antisene oligonucleotide
  • Functional genomics
  • Phosphorodiamidate morpholino oligonucleotide therapeutics
  • Zebrafish

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The zebrafish as a novel system for functional genomics and therapeutic development applications. / Nasevicius, A.; Ekker, Stephen C.

In: Current Opinion in Molecular Therapeutics, Vol. 3, No. 3, 2001, p. 224-228.

Research output: Contribution to journalArticle

@article{6dee923c62fc40f1bcabc45d70e21529,
title = "The zebrafish as a novel system for functional genomics and therapeutic development applications",
abstract = "Unconventional antisense technology has entered the mainstream for both therapeutic and functional genomics applications in a variety of biological settings. Further development of this approach has been hampered by the high cost and limited information obtained with standard bioassays and animal models. The embryo of the zebrafish Danio rerio offers both biologists and technologists a new strategy that rapidly garners efficacy, toxicity and specificity data in an in vivo setting. This system has been used to optimize current antisense targeting methods, and it provides an ideal initial assay system for the development of new chemistries or other new gene targeting approaches.",
keywords = "Antisene oligonucleotide, Functional genomics, Phosphorodiamidate morpholino oligonucleotide therapeutics, Zebrafish",
author = "A. Nasevicius and Ekker, {Stephen C}",
year = "2001",
language = "English (US)",
volume = "3",
pages = "224--228",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "3",

}

TY - JOUR

T1 - The zebrafish as a novel system for functional genomics and therapeutic development applications

AU - Nasevicius, A.

AU - Ekker, Stephen C

PY - 2001

Y1 - 2001

N2 - Unconventional antisense technology has entered the mainstream for both therapeutic and functional genomics applications in a variety of biological settings. Further development of this approach has been hampered by the high cost and limited information obtained with standard bioassays and animal models. The embryo of the zebrafish Danio rerio offers both biologists and technologists a new strategy that rapidly garners efficacy, toxicity and specificity data in an in vivo setting. This system has been used to optimize current antisense targeting methods, and it provides an ideal initial assay system for the development of new chemistries or other new gene targeting approaches.

AB - Unconventional antisense technology has entered the mainstream for both therapeutic and functional genomics applications in a variety of biological settings. Further development of this approach has been hampered by the high cost and limited information obtained with standard bioassays and animal models. The embryo of the zebrafish Danio rerio offers both biologists and technologists a new strategy that rapidly garners efficacy, toxicity and specificity data in an in vivo setting. This system has been used to optimize current antisense targeting methods, and it provides an ideal initial assay system for the development of new chemistries or other new gene targeting approaches.

KW - Antisene oligonucleotide

KW - Functional genomics

KW - Phosphorodiamidate morpholino oligonucleotide therapeutics

KW - Zebrafish

UR - http://www.scopus.com/inward/record.url?scp=0034947209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034947209&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 224

EP - 228

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 3

ER -